Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This brief warm-up applies equally to GLP-1 injection technique across all formulations and brands
When a new prescription drug enters the market, the question for employers isnt just does it work? Its what does covering it mean for our people, our plan, and our longterm costs? That question became especially relevant in early 2026, when an oral version of Wegovy entered the market with widespread media coverage
Are GLP-1s Worth It
has provided consultation to Eisai, Biogen, Lilly, Roche, Genentech, Bolden, Novo Nordisk, Prothena, Acumen Pharmaceuticals, Labcorp, Alector, Corium, Kisbee, Neurophet, Icometrix and AbbVie
Build a Network: Learn the benefits of a multi-faceted support network for comprehensive treatment plans, including therapists, fitness partners, and dieticians
